Search results
Results from the WOW.Com Content Network
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. [2]
CRL for a revoked cert of Verisign CA. There are two different states of revocation defined in RFC 5280: Revoked A certificate is irreversibly revoked if, for example, it is discovered that the certificate authority (CA) had improperly issued a certificate, or if a private-key is thought to have been compromised.
Bob, concerned that Alice's private key may have been compromised, creates an 'OCSP request' that contains Alice's certificate serial number and sends it to Carol. Carol's OCSP responder reads the certificate serial number from Bob's request. The OCSP responder uses the certificate serial number to look up the revocation status of Alice's ...
In United States pharmaceutical regulatory practice, a Complete Response Letter (CRL), or more rarely, a 314.110 letter, is a regulatory action by the Food and Drug Administration in response to a New Drug Application, Amended New Drug Application or Biologics License Application, indicating that the application will not be approved in its ...
In January 2003, Labcorp acquired Dianon, a provider of oncology and genomic diagnostic testing services, for $598 million in cash. [28] [29] [30] In February 2005, the company acquired US Pathology Labs Inc., a provider of anatomical pathology and oncology testing services, for $155 million. [20] [31]
Ensuring continuous, long-term access to "last-copy" paper and microform collections for the CRL community through coordinated archiving and collection-sharing arrangements with key partners. [ 2 ] In 2008, the Center for Research Libraries was awarded a $1.45 million grant from the Andrew W. Mellon Foundation to support this initiative.
These activities combined to increase the total number of employees in the global entity to more than 1300, with total 2015 revenues of $215 million. [2] In early 2016, Wilmington, MA-based Charles River Laboratories International, Inc. (NYSE:CRL), led by James C. Foster, acquired the global holdings of WIL Research for $585 million in cash.
Hospital labs may also outsource their lab, known as outreach, to run tests; however, health insurers may pay the hospitals more than they would pay a laboratory company for the same test, but as of 2016, the markups were questioned by insurers. [29] Rural hospitals, in particular, can bill for lab outreach under the Medicare's 70/30 shell rule ...